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Abstract	
Background	
As	more	regions	approach	malaria	elimination,	understanding	how	different	interventions	interact	to	
reduce	transmission	becomes	critical.	The	Lake	Kariba	area	of	Southern	Province,	Zambia,	is	part	of	a	
multi-country	elimination	effort	and	presents	a	particular	challenge	as	it	is	an	interconnected	region	of	
variable	transmission	intensities.		
	
Methods	
In	2012-13,	six	rounds	of	mass-screen-and-treat	drug	campaigns	were	carried	out	in	the	Lake	Kariba	
region.	A	spatial	dynamical	model	of	malaria	transmission	in	the	Lake	Kariba	area,	with	transmission	and	
climate	modeled	at	the	village	scale,	was	calibrated	to	the	2012-13	prevalence	survey	data,	with	case	
management	rates,	insecticide-treated	net	usage,	and	drug	campaign	coverage	informed	by	
surveillance.	The	model	was	used	to	simulate	the	effect	of	various	interventions	implemented	in	2014-
22	on	reducing	regional	transmission,	achieving	elimination	by	2022,	and	maintaining	elimination	
through	2028.	
	
Findings	
The	model	captured	the	spatio-temporal	trends	of	decline	and	rebound	in	malaria	prevalence	in	2012-
13	at	the	village	scale.	Simulations	predicted	that	elimination	required	repeated	mass	drug	
administrations	coupled	with	simultaneous	increase	in	net	usage.	Drug	campaigns	targeted	only	at	high-
burden	areas	were	as	successful	as	campaigns	covering	the	entire	region.	
	
Interpretation	
Elimination	in	the	Lake	Kariba	region	is	possible	through	coordinating	mass	drug	campaigns	with	high-
coverage	vector	control.	Targeting	regional	hotspots	is	a	viable	alternative	to	global	campaigns	when	
human	migration	within	an	interconnected	area	is	responsible	for	maintaining	transmission	in	low-
burden	areas.	
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Research	in	context	
Evidence	before	this	study	
As	malaria	transmission	declines	in	many	regions	around	the	world,	more	countries	are	developing	plans	
for	elimination.	In	the	southern	Africa	region,	elimination	within	the	next	decade	will	likely	require	a	
combination	of	vector	control	and	mass	drug	campaigns.	Mathematical	models	have	been	developed	to	
guide	policy	and	describe	features	of	successful	campaigns.	A	PubMed	search	on	March	7,	2016	of	
((malaria[Title])	AND	(model[Title]	OR	modeling[Title]	OR	modelling[Title])	AND	elimination)	for	all	
articles	to	date	yielded	52	results,	of	which	14	were	primary	research	articles	on	dynamical	malaria	
models	used	to	investigate	elimination.	Of	the	14,	five	modeled	a	specific	geographical	region,	two	were	
spatial	models	at	the	province	level,	and	one	included	human	mobility.	All	models	predict	mass	drug	
administration	to	be	more	effective	at	reducing	transmission	than	mass	screen-and-treat.	
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Added	value	of	this	study	
This	is	the	most	comprehensive	effort	to	date	to	capture	and	model	malaria	transmission	within	any	
specific	geographical	context,	and	by	modeling	at	the	village	level,	this	is	also	the	finest-resolution	
spatial	model	of	malaria.	For	the	first	time,	this	study	addresses	the	requirements	for	elimination	in	a	
non-generalized	setting	whose	interconnectedness	and	spatial	variation	in	transmission	present	
substantial	barriers	to	achieving	elimination.	
	
Implications	of	all	the	available	evidence	
Elimination	is	possible	in	this	challenging	region,	and	thus	likely	throughout	southern	Africa,	if	mass	drug	
administrations	are	coupled	with	simultaneous	high-coverage	vector	control.	Targeting	regional	
hotspots	of	transmission	is	a	viable	way	to	conserve	resources	without	sacrificing	campaign	success.	
	
	
Introduction	
	
Malaria	is	a	vector-borne	parasitic	disease	affecting	millions	of	people	worldwide,	with	Plasmodium	
falciparum	still	causing	over	400,000	deaths	per	year.1	Recent	escalation	in	vector	control	has	greatly	
reduced	global	burden	and	brought	many	regions	close	to	elimination.2	In	some	settings,	mass	drug	
campaigns	have	been	an	effective	tool	for	depleting	the	human	infectious	reservoir	and	breaking	the	
cycle	of	transmission,	although	the	effectiveness	of	such	campaigns	has	been	mixed.3		
The	ultimate	goal	is	global	malaria	eradication,	but	the	extreme	heterogeneity	in	transmission	levels,	
vector	bionomics,	health	systems,	and	population	densities	limit	the	applicability	of	any	single	strategy.4	
Elimination	at	a	single	country	level	could	be	challenging	to	maintain	in	the	presence	of	high	cross-
border	movements	of	infected	individuals,	depending	on	the	country	and	its	regional	context.4	As	a	
result,	the	concept	and	implementation	of	regional	malaria	eliminations	provides	a	useful	staging	for	
progress	towards	eventual	global	eradication.5		
Southern	Africa	is	one	region	where	programs	are	planning	operational	strategies	for	elimination.6	
Elimination	in	southern	Africa	requires	elimination	in	the	Lake	Kariba	region	of	Southern	Province,	
Zambia,	where	areas	of	high-	and	low-intensity	transmission	are	interconnected.	Understanding	how	to	
achieve	elimination	in	the	microcosm	of	the	Lake	Kariba	area	would	provide	a	solution	to	how	to	
achieve	elimination	in	Southern	Africa	and	possibly	in	a	number	of	other	challenging	settings.	
The	Zambia	National	Malaria	Control	Centre	has	successfully	scaled	up	recommended	malaria	control	
interventions	over	the	past	decade	and	is	pursuing	alternative	methods	to	further	reduce	malaria	
transmission,	including	community-targeted	parasite	reservoir	reduction	strategies.7,8	Beginning	in	2012,	
mass	drug	campaigns	have	been	carried	out	annually	in	the	Lake	Kariba	region	of	Southern	Province,	
Zambia	(Figure	1),	where	transmission	is	seasonal	and	spatially	variable.		
Understanding	the	small-scale	variation	in	the	interconnected	Lake	Kariba	region	through	mathematical	
modeling	provides	important	insights	into	the	critical	thresholds	for	successful	outcomes.	Previous	
modeling	efforts	have	provided	guidance	for	conducting	successful	campaigns	in	generic	settings,9–11	yet	
limited	work	has	been	done	on	understanding	how	a	specific	geography's	individual	features	can	also	
affect	campaign	outcomes12,13	or	how	spatial	variation	in	vectorial	capacity	can	sustain	transmission	in	
interconnected	areas.	In	this	work,	the	most	detailed	spatial	model	of	a	specific	geography	to	date	is	
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constructed	and	used	to	predict	how	various	factors	such	as	variation	in	transmission	intensity	and	
human	migration	patterns	interact	to	influence	the	success	of	control	and	elimination	efforts.		
Local	transmission	dynamics	were	reconstructed	within	a	mechanistic	model	of	malaria	transmission	
using	the	high-resolution	surveillance	data	collected	during	the	mass	drug	campaigns	of	2012-13	in	the	
Lake	Kariba	region,	which	included	infection	status,	age,	GPS	coordinates	of	households,	recent	
symptoms,	recent	treatment,	and	insecticide-treated	net	(ITN)	usage.	Village-scale	biting	rates	were	
selected	to	calibrate	local	malaria	prevalence	and	incidence	to	longitudinal	surveillance	data	and	
seasonal	patterns	of	clinical	case	counts	reported	at	health	facilities	respectively.		
The	simulation	framework	was	then	used	to	assess	the	outcome	of	a	variety	of	post-2016	intervention	
scenarios.	Simulations	predict	that	on	their	own,	mass	drug	administrations	(MDAs),	high-coverage	ITN	
distributions,	and	ramp-ups	in	case	management	do	not	result	in	regional	elimination	within	the	next	
decade.	However,	elimination	is	simulated	to	be	likely	if	these	interventions	can	be	deployed	
simultaneously	at	high	coverage.	
	
Methods	
	
Study	site	overview	
	
During	each	of	the	2012	and	2013	dry	seasons	(June-November)	in	Southern	Province,	Zambia,	three	
large-scale	mass-screen-and-treat	(MSAT)	rounds	were	undertaken.	Individuals	were	visited	at	their	
homes	in	a	full	community	census	and,	following	consent,	administered	rapid	diagnostic	tests	(RDT).	
Test-positive	individuals	were	treated	with	the	antimalarial	drug	artemether-lumefantrine	(AL),	of	which	
the	first	dose	was	directly	observed.	During	each	MSAT	round,	RDT	results	were	geo-tagged	by	
household	location.	Information	was	collected	on	household	demographics,	ITN	usage,	recent	fevers,	
and	recent	drug	treatments.	
In	this	analysis,	focus	was	restricted	to	a	contiguous	block	of	twelve	health-facility	catchment	areas	
(HFCAs)	in	Gwembe	and	Sinazongwe	Districts	along	Lake	Kariba	(Figure	1).	These	HFCAs	cover	
approximately	80,000	people	living	in	a	geographic	area	spanning	a	range	of	endemic	malaria	
transmission	intensities.	
	
Constructing	a	detailed	spatial	model	of	malaria	transmission	in	the	Lake	Kariba	region	
	
High-resolution	spatial	simulations	were	conducted	with	EMOD	v2·0,	a	mechanistic,	individual-based	
model	of	malaria	transmission	including	vector	life	cycle	dynamics	and	within-host	immunity.14,15	
Demographics,	migration,	ITN	usage,	treatment-seeking,	and	drug	campaign	coverage	in	simulations	
were	informed	by	survey	data	collected	during	the	MSAT	rounds	(Figures	S1-S7).	Spatial	variation	in	
transmission	intensity	was	captured	by	selecting	local	vector	larval	habitat	availabilities	to	match	
observed	seasonal	and	spatial	patterns	in	RDT	prevalence	and	clinical	incidence.	Details	are	provided	in	
Supplemental	Methods.	
Household	locations	within	the	twelve	HFCAs	were	aggregated	to	115	village-sized	clusters	(Figure	1).	
Migration	rates	between	clusters	were	approximated	by	a	gravity	model	based	on	local	roads,	estimated	
travel	times,	and	fraction	of	longitudinally-linked	individuals	found	in	different	clusters	in	subsequent	
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surveillance	rounds.	Cluster-specific	daily	temperature,	humidity,	and	rainfall	were	estimated	from	
weather	station	data	and	the	NOAA	African	Rainfall	Estimation	Algorithm.16		
ITN	usage	was	determined	by	cluster-level	reported	usage	in	the	2012-13	survey	and	historical	estimates	
from	the	Malaria	Atlas	Project.2,17	ITN	usage	among	adolescents	was	modeled	at	half	that	of	other	
individuals.	Community-level	ITN	effects	were	similar	between	surveillance	and	simulation	data.	Case	
management	with	AL	was	modeled	uniformly	across	all	clusters	beginning	in	January	2007	according	to	
the	mean	fraction	of	individuals	with	fever	within	the	last	two	weeks	who	sought	treatment	as	reported	
in	surveillance	data.		
Clusters	were	assigned	to	one	of	three	drug	campaign	coverage	levels	based	on	average	HFCA	coverage	
estimated	from	longitudinally-linked	individuals	found	during	the	2012-13	campaigns.	Each	MSAT	
campaign	included	three	rounds	with	independent	coverage	and	assumed	full	compliance	with	drug	
regimens.	
Given	cluster-specific	ITN	usage	and	MSAT	coverage,	cluster-specific	transmission	intensity	was	
determined	by	sampling	over	a	range	of	larval	habitat	availabilities	for	Anopheles	arabiensis	and	An.	
funestus.	Both	cluster-level	prevalence	by	RDT	from	the	six	MSAT	rounds	in	2012-13	and	the	December	
2011	pilot	round	as	well	as	weekly	clinical	case	counts	from	the	Zambia	National	Malaria	Control	
Centre’s	Malaria	Rapid	Report	system	were	used	to	inform	the	selection	of	habitat	availability	at	each	
cluster.	Fit	quality	was	evaluated	based	on	the	weighted	sum	of	mean	square	error	of	prevalence	and	
rank	correlation	of	clinical	incidence.	
	
Predicting	outcomes	of	future	interventions	
	
Simulations	up	to	and	including	the	2012-13	MSAT	activities	were	extended	to	model	the	2014-15	MDAs	
carried	out	in	the	study	area,	where	simulated	MDA	campaigns	with	dihydroartemisinin-piperaquine	
(DP),	each	consisting	of	two	rounds	separated	by	60	days,	were	administered	to	all	clusters	in	December	
2014	and	July	2015.	During	MDA,	individuals	received	treatment	regardless	of	their	RDT	result.	
Simulations	were	followed	until	2028.	
Under	case	management	ramp-up,	treatment	rates	for	symptomatic	malaria	increased	after	2015	to	
>90%	by	2019.	Under	ramped-up	ITN	usage,	ITN	distributions	continued	between	2015	and	2022	at	
historical	rates.	Under	aggressive	ITN	usage,	ITNs	were	distributed	at	80%	coverage	every	two	years	
between	2016	and	2022.	All	simulated	individuals	with	an	ITN	used	their	net	every	night.	
For	simulations	where	MDAs	were	extended	through	2020,	two	rounds	of	MDAs	with	DP	were	
administered	beginning	each	July	for	the	five	years	from	2016-20.	Campaign	coverage	at	each	cluster	
was	set	at	the	cluster’s	2012-13	MSAT	coverage.	For	targeted	MDAs,	clusters	in	high-burden	HFCAs	
received	MDAs	from	2016-20	while	clusters	in	low-burden	HFCAs	did	not	receive	MDA	after	2015.	See	
Supplemental	Methods	for	details	on	intervention	scenarios.	
	
Role	of	the	funding	source	
The	funders	had	no	role	in	study	design,	data	analysis,	decision	to	publish,	or	preparation	of	the	
manuscript.	The	corresponding	author	had	full	access	to	all	data	in	the	study	and	had	final	responsibility	
for	the	decision	to	submit	for	publication.	
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Results	
	
Malaria	transmission	in	the	Lake	Kariba	region	
	
A	high-resolution	spatial	model	of	the	Lake	Kariba	study	site	was	configured	based	on	village-scale	
clusters	of	households	and	ITN	usage,	MSAT	coverage,	case	management,	and	human	migration	rates	
derived	from	the	2012-13	RDT	prevalence	surveys	(Figure	1,	Figures	S1-S7	and	Supplemental	Methods).	
Malaria	transmission	was	modeled	within	each	cluster,	where	vector	populations	were	driven	by	cluster-
specific	climate	data	and	local	abundance	of	larval	habitats.	
Preliminary	entomological	data	indicated	that	both	Anopheles	arabiensis	and	Anopheles	funestus	are	
present	in	the	study	area,	with	arabiensis	biting	rates	highest	between	January	and	April	during	the	
warm	rainy	season	while	funestus	peaks	in	September	at	the	beginning	of	the	hot	dry	season	(Figure	
2A).18	Relative	abundances	of	arabiensis	and	funestus	govern	the	seasonality	of	malaria	transmission,	
while	absolute	abundances	determine	the	intensity.	For	each	village-scale	cluster,	combinations	of	larval	
habitat	availabilities	for	arabiensis	and	funestus	were	simulated	with	appropriate	patterns	of	ITN	usage,	
case	management	rates,	and	MSAT	coverage.	The	resulting	simulated	prevalence	and	clinical	case	
counts	were	compared	with	surveillance	data	to	select	the	combination	of	habitats	yielding	the	best	fit	
to	field	observations	(Figure	2B,	Supplemental	Methods).	
Calibration	to	surveillance	data	resulted	in	the	expected	gradient	of	higher	habitat	availability	of	both	
vector	species	closer	to	Lake	Kariba	and	lower	availability	in	the	higher-altitude	HFCAs	more	distant	
from	the	lake	(Figure	2C).	Chiyabi	HFCA	was	predicted	to	have	the	largest	amount	of	funestus	in	this	
region,	suggesting	that	ITNs	may	be	particularly	effective	there	as	funestus	is	indoor-feeding	and	highly	
anthropophilic.19		
The	calibrated	simulations	captured	both	fine-scale	cluster-level	variation	in	malaria	prevalence	and	
large-scale	spatio-temporal	trends	of	temporary	reduction	in	prevalence	observed	in	the	study	area	
following	MSAT	rounds	(Figure	3A,	Figure	S8).	Surveillance	in	2012-13	reported	stalled	reduction	in	
prevalence	by	late	2012	and	rapid	rebound	after	the	following	rainy	season.	This	observation	was	
replicated	in	the	spatial	model,	where	significant	re-infection	between	rounds	two	and	three	in	lakeside	
clusters	drives	rebound	throughout	the	study	area.	
The	observed	seasonality	of	weekly	RDT-confirmed	clinical	cases	was	well-captured	by	simulations,	
including	a	characteristic	pattern	of	high	case	counts	between	December	and	June	and	a	small	rise	in	
cases	in	Chipepo	and	Sinamalima	HFCAs	as	temperatures	rise	in	October	(Figure	3B).	However,	in	many	
HFCAs	simulations	consistently	underestimated	the	magnitude	of	observed	case	counts.	While	
simulations	estimate	a	constant	proportion	of	clinical	cases	seek	care	at	health	facilities,	several	factors	
could	contribute	to	discrepancies	between	true	and	observed	clinical	incidence	in	the	field.	Gwembe	
HFCA,	which	otherwise	has	very	low	transmission,	contains	the	district	hospital.	Clinical	cases	reported	
from	Gwembe	HFCA	may	have	traveled	from	elsewhere	within	or	outside	the	study	area	expressly	to	
seek	care.	Case	management	rates	in	simulation	were	estimated	from	survey	responses	during	the	dry	
season,	while	individuals	with	fever	during	the	wet	season	may	show	different	health-seeking	behavior	
based	on	road	conditions	and	personal	assessment	of	whether	the	fever	is	malarial.	A	strong	distance-
dependence	on	health-seeking	(Figure	S4B)	means	households	closer	to	the	health	facility	contribute	
disproportionately	more	to	recorded	case	counts	than	to	true	clinical	incidence.	Lastly,	clinics	report	any	
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RDT-positive	individual	presenting	with	fever	as	a	clinical	case	of	malaria.	However,	a	substantial	portion	
of	individuals	in	malaria-endemic	areas	with	non-malarial	fevers	will	be	RDT-positive	due	to	low-density	
infection	or	recent	clearance	of	malaria.20,21		
	
Regional	elimination	requires	concerted	ITN	distributions,	drug	campaigns,	and	improvement	in	case	
management	
	
Incomplete	coverage	and	imperfect	diagnostics	in	MSAT	campaigns	result	in	a	significant	portion	of	the	
parasite	reservoir	being	left	untreated.21–25	This	untreated	reservoir	will	resume	the	cycle	of	
transmission	during	the	next	rainy	season.	However,	a	mass-distribution	mode	that	can	treat	
undetected	infections	and	a	drug	formulation	such	as	DP	with	longer	prophylactic	protection	against	re-
infection	will	be	more	successful	at	interrupting	transmission.10		
Operations	teams	in	the	Lake	Kariba	region	continued	mass	treatment	following	the	2012-13	MSAT	by	
administering	MDA	and	focal	MDA	to	a	randomized	group	of	HFCAs.	Simulations	approximated	
operational	activities	in	2014-15	by	administering	a	mass	distribution	of	ITNs	in	June	2014	and	MDA	with	
DP	to	all	HFCAs	in	December	2014	and	July	2015,	in	line	with	operational	schedules.	
To	compare	how	case	management,	ITN	usage,	and	MDA	coverage	contribute	to	reducing	malaria	
burden	separately	and	together,	a	variety	of	post-2015	intervention	scenarios	were	simulated.	For	each	
simulation,	the	fraction	of	the	study-area	population	living	in	clusters	with	prevalence	below	1%	was	
measured.	Because	simulated	migration	rates	were	high,	this	metric	approximates	the	extent	to	which	
the	entire	study	area	has	achieved	elimination.	
Discontinuing	MDAs	after	the	2015	rounds	while	maintaining	current	levels	of	ITN	usage	did	not	result	in	
long-term	reduction	in	regional	malaria	transmission	(Figure	4A).	Increasing	passive	case	management	
rates	established	a	new	baseline	of	lower	transmission	during	the	decade	following	the	end	of	MDAs	in	
2015	but	could	not	achieve	region-wide	elimination.	Combining	the	2014-15	MDAs	with	ramp-ups	in	
case	management	and	increased	ITN	usage	resulted	in	near-elimination	under	highly	aggressive	ITN	
distribution	campaigns	but	not	if	ITN	ramp-ups	followed	historical	rates	of	increase	(Figure	4B,	Figure	
S9).	Under	both	ITN	scenarios,	transmission	rebounded	after	the	last	ITN	distribution	in	2022	to	a	new	
baseline	largely	determined	by	case	management	rate.	Coverage	achieved	during	MDA	did	not	affect	
transmission	in	the	long	term	(Figure	S10).	
Extending	annual	dry-season	MDAs	through	2020	resulted	in	high	probability	of	complete	elimination	if	
ITN	usage	was	aggressively	increased,	but	not	if	ITN	usage	was	maintained	at	current	levels	or	ramped	
up	gradually	(Figure	4C,	Figure	S11).	Simulations	predict	that	elimination	in	the	Lake	Kariba	region	
requires	both	high	ITN	usage	to	reduce	vectorial	capacity	and	multi-year	MDAs	to	deplete	the	parasite	
reservoir.	
Restricting	post-2015	MDAs	to	high-burden	HFCAs	resulted	in	outcomes	comparable	to	cases	where	
MDAs	were	distributed	to	all	HFCAs	(Figure	4D).	Simulating	with	a	lower	migration	rate	under	less	
aggressive	ITN	distributions	showed	a	slower	rebound	in	transmission	after	2022,	suggesting	that	
success	of	targeted	approaches	is	highly	dependent	on	regional	spatial	connectivity.	
Unsurprisingly,	elimination	was	easier	to	achieve	in	clusters	situated	in	low-burden	HFCAs	(Figure	4E).	
Several	combinations	of	intervention	mixes	resulted	in	nearly	all	low-burden	clusters	maintaining	very	
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low	prevalence	through	January	2028	and	likely	interrupting	local	transmission.	Limiting	migration	
reduced	or	eliminated	transmission	even	in	several	high-burden	clusters,	suggesting	that	a	few	very	
high-burden	clusters	are	maintaining	transmission	throughout	the	entire	study	area.	
	
Discussion	
	
The	complex	spatial	dynamics	of	malaria	transmission	in	the	Lake	Kariba	region	of	Southern	Zambia	
were	captured	in	a	mathematical	model,	which	was	then	extended	to	compare	the	effects	of	future	
interventions.	The	simulation	framework	was	informed	by	household	surveillance	in	2012-13,	clinical	
case	counts	reported	by	local	clinics,	and	preliminary	entomological	data.	This	work	is	the	first	to	
examine	how	village-scale	variation	in	transmission	intensity	can	drive	transmission	throughout	an	
interconnected	region.	
While	the	2012-13	MSAT	surveys	were	a	rich	source	of	data	for	model-building,	they	presented	an	
incomplete	picture	of	local	malaria	transmission	because	measurements	were	taken	during	the	dry	
season.	The	seasonality	of	transmission	was	thus	difficult	to	characterize	based	solely	on	these	
measurements.	Weekly	clinical	case	counts	reported	from	health	facilities	were	broadly	informative	of	
transmission	during	the	remaining	months	of	the	year,	but	ascertaining	the	proportion	of	RDT-positive	
fevers	that	are	true	malarial	fevers	is	difficult.	The	seasonality	of	cases	observed	at	the	health	facility	
may	not	reflect	seasonality	of	transmission	in	every	village	within	the	HFCA	as	each	HFCA	may	
encompass	a	range	of	transmission	intensities.	Nonetheless,	simulations	were	able	to	recapture	both	
region-	and	village-scale	spatio-temporal	features	of	transmission	observed	during	the	2012-13	
operations.	
Local	entomology	drives	the	seasonality	of	transmission.	Attempting	to	model	the	study	area	with	only	
arabiensis	vectors	requires	non-seasonal	year-round	transmission	in	many	lakeside	areas	in	order	to	
capture	substantial	prevalence	during	the	November	surveys,	which	would	result	in	a	mismatch	with	
observed	seasonality	of	clinical	case	counts.	Incorporating	funestus	allowed	the	model	to	capture	both	
dry	season	prevalence	and	seasonal	patterns	of	clinical	cases.	More	entomological	data	on	vector	
species	abundance	and	behavior	will	guide	continued	model	refinements.	
All	simulations	assumed	full	compliance	with	drug	regimens.	While	perfect	adherence	to	treatment	is	
unlikely,26,27	elimination	is	possible	even	when	compliance	is	extremely	poor	(Figure	S12),	and	previous	
modeling	work	has	shown	that	compliance	is	not	crucial	in	mass	campaigns	in	settings	without	drug	
resistance.10	Most	individuals	who	harbor	dry	season	infections	have	low	parasite	densities,20,21	and	a	
single	dose	of	AL	or	DP	is	often	sufficient	to	clear	those	infections.	
Unlike	the	2012-13	MSATs,	the	2014-15	MDAs	correspond	to	a	dramatic	move	across	the	region	toward	
elimination.	However,	this	effect	is	short-term	unless	coupled	with	improvements	in	passive	case	
detection	and	vector	control.	In	this	study,	vector	control	has	been	modeled	exclusively	as	ITN	usage,	
but	indoor	residual	spraying	(IRS)	would	have	similar	effects	if	local	vectors	are	susceptible.	Combining	
IRS	and	ITNs	may	likely	represent	a	more	attainable	scenario	for	aggressive	vector	control	given	that	ITN	
usage	has	a	large	and	unpredictable	behavioral	component.	Simulations	predict	that	elimination	is	
highly	likely	if	MDAs	are	continued	for	a	few	more	years	and	vector	control	remains	very	aggressive,	
although	as	predicted	by	generic	models,28	even	in	this	context	transmission	can	occasionally	rebound	
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after	vector	control	ceases	(Figure	S11).	Rebound	in	transmission	depends	on	the	extent	of	human	
movement	as	travelers	from	high-transmission	areas	re-seed	transmission	in	low-transmission	areas.	
Targeting	MDAs	to	high-burden	areas	is	potentially	a	reasonable	approach	to	saving	resources	while	
achieving	comparable	outcomes	to	non-targeted	approaches,	and	could	even	result	in	improved	
outcomes	if	better	coverage	with	vector	control	can	be	achieved	in	targeted	areas.	Simulations	predict	
that	as	long	as	passive	case	management	improves,	malaria	transmission	will	die	out	in	low-burden	
areas.	While	generic	models	have	predicted	that	targeting	transmission	foci	would	be	effective,29	this	
study	demonstrates	for	the	first	time	that	elimination	strategies	in	interconnected	regions	are	better	
served	by	focusing	directly	on	reducing	transmission	in	regional	hotspots	rather	than	attempting	to	
maintain	an	“elimination	front”	and	tackling	the	most	difficult	areas	last.	Programs	will	need	to	identify	
where	regional	hotspots	are	located,	with	the	understanding	that	hotspot	locations	and	intensities	can	
change	dynamically	as	interventions	are	deployed	and	changes	in	vector	species	composition,	human	
movement	patterns,	housing	conditions,	and	climatic	cycles	alter	the	local	landscape	of	transmission.	
As	more	regions	reduce	transmission	and	approach	malaria	elimination,	it	becomes	crucial	to	
understand	how	to	set	up	malaria	operations	for	successful	and	lasting	elimination	at	local,	national,	and	
regional	levels.	Southern	Africa	is	a	particular	challenge	as	vectorial	capacity	is	substantial	in	some	areas	
and	the	region	has	become	increasingly	interconnected.	This	study	suggests	that	elimination	in	the	
southern	Africa	region	will	require	several	years	of	concerted	vector	control	and	mass	drug	campaigns	
that	systematically	target	local	transmission	hotspots	within	the	region.	Ultimately,	it	follows	that	
regional	malaria	elimination	in	southern	Africa	is	nevertheless	within	reach	with	current	tools,	provided	
the	efficacy	and	operational	efficiency	attained	in	the	Lake	Kariba	operational	area	can	be	extended	and	
targeted	to	other	key	areas.	
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Figure	legends	
	
Figure	1.	Households	in	the	Lake	Kariba	region	of	Southern	Province,	Zambia,	are	clustered	into	village-
scale	simulation	constructs	within	twelve	health	facility	catchment	areas.	
	
Figure	2.	Spatial	distribution	of	two	vector	species	is	calibrated	to	prevalence	survey	and	clinical	case	
count	data.	(A)	Adult	vector	numbers	are	tuned	by	scaling	larval	habitat	availability	of	An.	arabiensis	and	
An.	funestus	vectors.	Relative	scales	of	the	two	vector	species	govern	the	seasonality	of	human	biting.	
Shown:	arabiensis	scale	=	100,	funestus	scale	=	30.	(B)	Representative	calibration	of	larval	habitat	
availabilities	in	a	Chabbobboma	HFCA	cluster.	Sampling	over	larval	habitat	availability	scale	factors	for	
arabiensis	and	funestus	identifies	combinations	of	scale	factors	with	good	fits	to	RDT	prevalence	from	
surveillance	data.	Incorporating	scores	from	comparisons	of	cluster-level	simulated	clinical	case	counts	
to	HFCA-level	reported	clinical	case	counts	results	in	improved	fit	to	the	seasonality	of	clinical	incidence	
while	maintaining	good	fit	to	observed	prevalence.	Cluster-level	simulated	clinical	case	counts	were	
scaled	to	match	HFCA-wide	populations.	(C)	Best	fit	arabiensis	and	funestus	larval	habitat	availabilities	
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vary	spatially	over	the	study	region,	with	more	habitat	available	for	both	species	in	the	lower-altitude	
regions	closer	to	the	lake	front.	
	
Figure	3.	Simulated	malaria	transmission	in	the	Lake	Kariba	region	shows	good	agreement	with	
surveillance	data.	(A)	Spatio-temporal	variation	in	cluster-level	prevalence	of	RDT-positive	infections	is	
well-captured	by	simulation.	Top:	survey	data	collected	during	MSAT	rounds.	Bottom:	mean	cluster	
prevalence	in	ten	stochastic	simulation	realizations.	(B)	Simulations	capture	the	seasonality	of	HFCA-
level	weekly	clinical	case	counts.	Simulated	clinical	and	severe	malaria	cases	are	scaled	by	32%	to	
estimate	the	fraction	seeking	treatment	in	clinics.	Mean	(line)	and	range	(shaded	area)	of	ten	stochastic	
realizations.	
	
Figure	4.	Malaria	elimination	in	the	Lake	Kariba	region	requires	deployment	of	mass	drug	campaigns,	
high	levels	of	ITN	usage,	and	improved	case	management	rates.	(A)	Transmission	reduction	if	no	MDAs	
are	conducted	after	2015	and	ITN	usage	is	not	increased.	Degree	of	regional	elimination	is	measured	as	
the	fraction	of	the	total	population	living	in	village-clusters	with	RDT	prevalence	below	1%.	All	traces	
show	the	mean	(line)	and	range	(shaded	area)	of	ten	stochastic	realizations.	See	Supplemental	Methods	
for	details.	(B)	Transmission	reduction	if	no	MDAs	are	conducted	after	2015,	case	management	is	
ramped	up,	and	ITN	usage	is	increased	between	2015-22.	(C)	Transmission	reduction	if	MDAs	continue	
through	2020	and	case	management	is	ramped	up.	(D)	Transmission	reduction	if	MDAs	between	2016	
and	2020	are	distributed	only	to	high-burden	HFCAs	and	case	management	is	ramped	up.	(E)	Cluster	
RDT	prevalence	in	December	2027	for	ten	possible	scenarios	of	future	interventions.	Clusters	are	divided	
into	high-burden	(n=64)	and	low-burden	(n=51)	groups	as	indicated	in	Fig	4D.	Cluster	prevalence	is	the	
mean	of	ten	stochastic	realizations.	
	
Supporting	Information	
Supplemental	Methods	
Figure	S1.	Surveillance	and	simulation	demographics.	
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Figure	S4.	Health-seeking	in	surveillance	and	simulation.	
Figure	S5.	MSAT	coverage	by	HFCA.	
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